-transparent.png){kind=logo}
Administration of[3H]aflatoxin B2 (2,3-dihydroaflatoxin B1)(AFB2) to male rats resulted in levels of hepatic DNA- and ribosomal(r)RNA-aflatoxin adducts that were about 1% of those for rats given [3H]aflatoxin B1(AFB1). The levels of hepatic protein-aflatoxin adducts were 35 to 70% as great for AFB2-treated as compared to AFB1-treated rats...
Related Publications
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
November 1980,
Chemico-biological interactions,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
August 1985,
Cancer research,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
February 1984,
Proceedings of the National Academy of Sciences of the United States of America,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
October 1985,
Experientia,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
July 1987,
Mutation research,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
December 1977,
Cancer research,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
June 1980,
Food and cosmetics toxicology,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
March 1966,
Science (New York, N.Y.),
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
January 1984,
Journal of toxicology and environmental health,
D H Swenson, and
J K Lin, and
E C Miller, and
J A Miller
October 1974,
Biochemical and biophysical research communications,
